109 related articles for article (PubMed ID: 6492397)
1. [Pharmacophysiological functions of bile acids].
Takagi I; Shibata K; Kameda H
Nihon Rinsho; 1984 Jul; 42(7):1555-9. PubMed ID: 6492397
[No Abstract] [Full Text] [Related]
2. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
3. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
Nilsell K
Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
[No Abstract] [Full Text] [Related]
4. Cheno and urso compared and contrasted.
Dowling RH
Acta Med Port; 1983 Jan; 4(1):51-62. PubMed ID: 6337454
[No Abstract] [Full Text] [Related]
5. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
[No Abstract] [Full Text] [Related]
6. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
Nowak M; Panveliwalla D; Pertsemlidis D
Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
[No Abstract] [Full Text] [Related]
7. [Clinical significance of bile acids].
Schmack B
Fortschr Med; 1979 Apr; 97(15):690-3. PubMed ID: 456969
[TBL] [Abstract][Full Text] [Related]
8. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
Fromm H
Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
[No Abstract] [Full Text] [Related]
9. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
Zak RA; Marks JW; Schoenfield LJ
Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
[No Abstract] [Full Text] [Related]
10. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
Makino I; Yoneda M; Tamasawa N; Takebe K
Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
[No Abstract] [Full Text] [Related]
11. [Medical treatment of gallstones (author's transl)].
Gérolami A; Montet JC; Marteau C; Reynier MO; Crotte C
Gastroenterol Clin Biol; 1980; 4(8-9):588-99. PubMed ID: 7000610
[No Abstract] [Full Text] [Related]
12. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
[No Abstract] [Full Text] [Related]
13. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
15. Bile salts: their role in cholesterol synthesis, secretion and lithogenesis.
Brandt LJ; Bernstein LH
Am J Gastroenterol; 1976 Jan; 65(1):17-30. PubMed ID: 1274926
[No Abstract] [Full Text] [Related]
16. Medical therapy for gallstones. 1. Rationale and indications.
Carey WD; Tangedahl TN
Postgrad Med; 1982 May; 71(5):163-72. PubMed ID: 7041102
[No Abstract] [Full Text] [Related]
17. [Dissolution of biliary calculi with CDCA and UDCA].
Sugata F
Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
[No Abstract] [Full Text] [Related]
18. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
Garrido G; Bretó M; Pérez F; Berenguer J
Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274
[No Abstract] [Full Text] [Related]
20. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
Whiting MJ; Watts JM
Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
